Cambridge, MA, United States of America

Stephen C Blacklow

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Stephen C. Blacklow

Introduction

Stephen C. Blacklow is an innovative inventor based in Cambridge, MA, known for his significant contributions to the field of biomedical research. With two patents to his name, Blacklow has dedicated his career to understanding complex biological systems and developing new therapeutic strategies.

Latest Patents

Blacklow's recent work has led to the development of two notable patents. The first patent focuses on "NOTCH mutations leading to increased receptor signaling." This invention identifies crucial regions within the NOTCH-1 receptor that, when mutated, result in heightened receptor signaling. This signaling pathway is linked to uncontrolled cellular growth, which may be targeted using agents that inhibit NOTCH-1 activity, such as gamma-secretase inhibitors. This discovery holds the potential for diagnostic and therapeutic applications in cancer treatment.

The second patent, titled "RAP variants for drug delivery and methods of use thereof," centers around stabilized RAP (Receptor Associated Protein) variants and their applications. This patent covers conjugates formed from stabilized RAP variants linked to therapeutic compounds, as well as stabilized RAP fusion proteins containing therapeutic polypeptides. These advancements could enhance drug delivery systems for improved clinical outcomes.

Career Highlights

Throughout his career, Stephen C. Blacklow has made impactful contributions while working with prominent institutions such as Brigham and Women’s Hospital and Dana-Farber Cancer Institute. His research focuses on unraveling the complexities of cellular signaling and developing innovative treatments that harness these insights.

Collaborations

Blacklow has collaborated with notable personalities in the field, including Carl Fisher and Kristine Estrada. These partnerships have enabled him to advance his research and translate scientific discoveries into practical therapeutic applications.

Conclusion

Stephen C. Blacklow exemplifies the spirit of innovation through his groundbreaking patents and collaborations. His work not only enhances our understanding of critical biological processes but also paves the way for future advancements in cancer treatment and drug delivery systems. As a leading inventor, Blacklow continues to inspire the scientific community and contribute to the advancement of medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…